Microbiome Analysis Platform
Dysbiosis-related disease detection
Key Facts
About H.U. Group Holdings
H.U. Group Holdings Inc. (formerly Miraca Holdings Inc.) is a leading Japanese healthcare diagnostics company listed on the Tokyo Stock Exchange, structured around high-volume clinical laboratory testing and advanced diagnostic reagent manufacturing. The company's mission centers on supporting disease prevention, diagnosis, and treatment through its Testing Services and IVD segments, leveraging subsidiaries including SRL, Inc. and the Fujirebio group. With expertise spanning enzyme immunoassay, chemiluminescent technologies, and biomarker discovery, H.U. Group is strategically expanding into companion diagnostics and liquid biopsy platforms to capitalize on the precision medicine revolution. The company's dominant market position in Japan, combined with its technological depth and integrated value chain approach, positions it as a critical infrastructure player in global diagnostics.
View full company profile